Anti-E2F3 antibody
- KO Validated
- What is this?
Be the first to review this product! Submit a review
|
(14 Publications)
Rabbit Polyclonal E2F3 antibody. Suitable for WB and reacts with Human samples. Cited in 14 publications. Immunogen corresponding to Recombinant Fragment Protein within Human E2F3 aa 150-450.
View Alternative Names
KIAA0075, E2F3, Transcription factor E2F3, E2F-3
- WB
Lab
Western blot - Anti-E2F3 antibody (AB152126)
False colour image of Western blot : Anti-E2F3 antibody staining at 1/500 dilution, shown in green; Mouse anti-GAPDH antibody [6C5] (ab8245) loading control staining at 1/20000 dilution, shown in red. In Western blot, ab152126 was shown to bind specifically to E2F3. A band was observed at 49 kDa in wild-type HeLa cell lysates with no signal observed at this size in E2F3 knockout cell line ab265362 (knockout cell lysate ab257415). To generate this image, wild-type and E2F3 knockout HeLa cell lysates were analysed. First, samples were run on an SDS-PAGE gel then transferred onto a nitrocellulose membrane. Membranes were blocked in 3 % milk in TBS-0.1 % Tween® 20 (TBS-T) before incubation with primary antibodies overnight at 4 °C. Blots were washed four times in TBS-T, incubated with secondary antibodies for 1 h at room temperature, washed again four times then imaged.Secondary antibodies used were Goat anti-Rabbit IgG H&L (IRDye® 800CW) preabsorbed (ab216773) and Goat anti-Mouse IgG H&L (IRDye® 680RD) preabsorbed (ab216776) at 1/20000 dilution.
All lanes:
Western blot - Anti-E2F3 antibody (ab152126) at 1/500 dilution
Lane 1:
Wild-type HeLa cell lysate at 20 µg
Lane 2:
E2F3 knockout HeLa cell lysate at 20 µg
Lane 2:
Western blot - Human E2F3 knockout HeLa cell line (<a href='/en-us/products/cell-lines/human-e2f3-knockout-hela-cell-line-ab265362'>ab265362</a>)
Lane 3:
SH-SY5Y cell lysate at 20 µg
Lane 4:
U-87 MG cell lysate at 20 µg
Predicted band size: 49 kDa
Observed band size: 49 kDa
false
- WB
Unknown
Western blot - Anti-E2F3 antibody (AB152126)
10% SDS PAGE
All lanes:
Western blot - Anti-E2F3 antibody (ab152126) at 1/1000 dilution
All lanes:
293T whole cell lysate at 30 µg
Predicted band size: 49 kDa
false
Reactivity data
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
E2F3 forms part of the E2F/DP protein complex which controls cell cycle entry and progression. Its activity facilitates the transcription of genes essential for DNA replication and synthesis. Through its interaction with retinoblastoma proteins specifically pRB and p107 E2F3 modulates cellular proliferation. This regulation is vital for maintaining normal cellular functions and growth ensuring proper cell cycle checkpoints are upheld.
Pathways
E2F3 participates in the RB/E2F signaling pathway a major controller of cell proliferation and apoptosis. This pathway serves a critical function in the decision between cell cycle progression and arrest. E2F3 interacts with cyclins and cyclin-dependent kinases (CDKs) particularly CDK2 highlighting its role in the regulation of cell cycle dynamics. It also works alongside other E2F family members such as E2F1 and E2F2 to maintain the balance between cell growth and death.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (14)
Recent publications for all applications. Explore the full list and refine your search
Journal of Cancer 14:1362-1370 PubMed37283793
2023
Applications
Unspecified application
Species
Unspecified reactive species
Aging 15:2689-2704 PubMed37053020
2023
Applications
Unspecified application
Species
Unspecified reactive species
Frontiers in aging neuroscience 14:811481 PubMed35615594
2022
Applications
Unspecified application
Species
Unspecified reactive species
Journal of oncology 2022:1866972 PubMed35237319
2022
Applications
Unspecified application
Species
Unspecified reactive species
Thoracic cancer 13:783-794 PubMed35083866
2022
Applications
Unspecified application
Species
Unspecified reactive species
Bioengineered 12:9046-9057 PubMed34657558
2021
Applications
Unspecified application
Species
Unspecified reactive species
Clinics (Sao Paulo, Brazil) 76:e3036 PubMed34644734
2021
Applications
Unspecified application
Species
Unspecified reactive species
Molecular medicine reports 24: PubMed34080033
2021
Applications
Unspecified application
Species
Unspecified reactive species
Oncology letters 21:411 PubMed33841572
2021
Applications
Unspecified application
Species
Unspecified reactive species
Frontiers in oncology 10:607231 PubMed33680929
2021
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com